| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |